ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,071Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 97

$627K Total Retail Price of All Prescriptions

Rank: 20 out of 97

557 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 557 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 557 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 9,816 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
SIMVASTATIN 648 583 1 2
LEVOTHYROXINE SODIUM 380 318 2 1
AMLODIPINE BESYLATE 360 329 3 6
FUROSEMIDE 344 312 4 3
LISINOPRIL 323 308 5 4
METOPROLOL TARTRATE 318 284 6 7
OMEPRAZOLE 313 298 7 5
METOPROLOL SUCCINATE 258 238 8 8
POTASSIUM CHLORIDE 240 227 9 10
ATENOLOL 232 224 10 15
METFORMIN HCL 232 179 10 12
ATORVASTATIN CALCIUM 228 199 12 14
SERTRALINE HCL 212 210 13 16
WARFARIN SODIUM 206 192 14 11
HYDROCHLOROTHIAZIDE 200 176 15 9
DONEPEZIL HCL 147 147 16 24
DIGOXIN 129 128 17 26
LOSARTAN POTASSIUM 126 126 18 13
GABAPENTIN 124 78 19 18
ENALAPRIL MALEATE 124 124 19 47
TRAMADOL HCL 117 115 21 21
LANTUS 115 101 22 43
HYDROCODONE-ACETAMINOPHEN 104 83 S3 23 17
ISOSORBIDE MONONITRATE ER 103 90 24 27
CITALOPRAM HBR 102 91 25 20
ZOLPIDEM TARTRATE 100 98 26 32
CLOPIDOGREL 96 87 27 34
INSULIN SYRINGE 95 83 28 88
AMITRIPTYLINE HCL 87 64 R 29 54
LANTUS SOLOSTAR 84 82 30 41
TRAZODONE HCL 82 81 31 42
PREDNISONE 80 69 32 23
CRESTOR 79 71 33 29
CARVEDILOL 73 65 34 25
HUMALOG 68 63 35 77
PLAVIX 66 56 36 46
PRAVASTATIN SODIUM 66 66 36 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 65 38 36
GLIMEPIRIDE 65 48 38 39
ZETIA 64 39 40 51
GLYBURIDE 64 56 R 40 75
HUMULIN 70-30 57 53 42 175
TAMSULOSIN HCL 52 43 43 31
NOVOLOG FLEXPEN 52 43 43 74
PEN NEEDLE 51 50 45 57
DIOVAN 51 41 45 44
HUMALOG MIX 75-25 51 50 45 233
ALLOPURINOL 50 34 48 22
TRICOR 50 39 48 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 23, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.